These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 17037312)

  • 1. [Pathophysiological significance of RAS in formation of arteriosclerosis].
    Matsubara H; Yamada H; Tsubakimoto Y; Yokoi H
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1762-8. PubMed ID: 17037312
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-atherosclerotic effect].
    Takai S; Miyazaki M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():518-23. PubMed ID: 16895221
    [No Abstract]   [Full Text] [Related]  

  • 3. [Protective effect of ARB on vascular diseases].
    Kim-Mitsuyama S
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():475-81. PubMed ID: 16895216
    [No Abstract]   [Full Text] [Related]  

  • 4. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis.
    Nickenig G; Harrison DG
    Circulation; 2002 Jan; 105(3):393-6. PubMed ID: 11804998
    [No Abstract]   [Full Text] [Related]  

  • 5. [Multiphasic action of AT1 receptor blockers and their therapeutic effects for cardiovascular diseases].
    Mitsuyama K
    Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):176-7. PubMed ID: 18350678
    [No Abstract]   [Full Text] [Related]  

  • 6. [Tissue angiotensin II generating system].
    Miyazaki M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():57-62. PubMed ID: 16895169
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin II and the endothelium: diverse signals and effects.
    Watanabe T; Barker TA; Berk BC
    Hypertension; 2005 Feb; 45(2):163-9. PubMed ID: 15630047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy for metabolic syndrome].
    Node K
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1737-41. PubMed ID: 17037308
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome.
    Prasad A; Quyyumi AA
    Circulation; 2004 Sep; 110(11):1507-12. PubMed ID: 15364819
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mechanism of vascular endothelial dysfunction induced by hypertension].
    Kawata H
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():38-42. PubMed ID: 15171338
    [No Abstract]   [Full Text] [Related]  

  • 11. The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation.
    Nickenig G; Harrison DG
    Circulation; 2002 Jan; 105(4):530-6. PubMed ID: 11815439
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of angiotensin II receptor blockers in animal models of atherosclerosis.
    Ferrario CM
    Am J Hypertens; 2002 Jan; 15(1 Pt 2):9S-13S. PubMed ID: 11824874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin-angiotensin system in atherosclerosis].
    Fukuda D; Sata M
    Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebroprotection with calcium channel blockers].
    Mogi M; Iwai M; Horiuchi M
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():531-5. PubMed ID: 16895222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Endothelial protection by angiotensin II type-1 receptor blockade].
    Yamada H; Matsui A; Tsubakimoto Y; Yokoi H; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():482-6. PubMed ID: 16897883
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial AT(2)-receptors: chicken or egg?
    Vanhoutte PM
    Br J Pharmacol; 2002 Jun; 136(4):481-3. PubMed ID: 12055125
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of the renin-angiotensin system in the development of cardiovascular disease.
    Unger T
    Am J Cardiol; 2002 Jan; 89(2A):3A-9A; discussion 10A. PubMed ID: 11835903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Programmed cellular death and atherogenesis: from molecular mechanisms to clinical aspects].
    Lesauskaite V; Ivanoviene L; Valanciūte A
    Medicina (Kaunas); 2003; 39(6):529-34. PubMed ID: 12829874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.